These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Treatment
34 results:

  • 1. SOX4 induces drug resistance of colorectal cancer cells by downregulating cyld through transcriptional activation of microRNA-17.
    Pan S; Bao D; Li Y; Liu D; Quan S; Wang R
    J Biochem Mol Toxicol; 2022 Jan; 36(1):e22910. PubMed ID: 34927777
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Asparagus racemosus and Geodorum densiflorum lectins induce apoptosis in cancer cells by altering proteins and genes expression.
    Kabir SR; Islam J; Ahamed MS; Alam MT
    Int J Biol Macromol; 2021 Nov; 191():646-656. PubMed ID: 34582909
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Whole Grain Intakes Are Associated with Healthcare Cost Savings Following Reductions in Risk of colorectal cancer and Total cancer Mortality in Australia: A Cost-of-Illness Model.
    Abdullah MMH; Hughes J; Grafenauer S
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578860
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma.
    Goedegebuure RSA; Harrasser M; de Klerk LK; van Schooten TS; van Grieken NCT; Eken M; Grifhorst MS; Pocorni N; Jordanova ES; van Berge Henegouwen MI; Pouw RE; Verheul HMW; van der Vliet JJ; van Laarhoven HWM; Thijssen VLJL; Bass AJ; De Gruijl TD; Derks S
    Oncoimmunology; 2021; 10(1):1954807. PubMed ID: 34377591
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circulating Hybrid Cells: A Novel Liquid Biomarker of treatment Response in Gastrointestinal cancers.
    Walker BS; Sutton TL; Zarour L; Hunter JG; Wood SG; Tsikitis VL; Herzig DO; Lopez CD; Chen EY; Mayo SC; Wong MH
    Ann Surg Oncol; 2021 Dec; 28(13):8567-8578. PubMed ID: 34365557
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Irreversible JNK blockade overcomes PD-L1-mediated resistance to chemotherapy in colorectal cancer.
    Sun L; Patai ÁV; Hogenson TL; Fernandez-Zapico ME; Qin B; Sinicrope FA
    Oncogene; 2021 Aug; 40(32):5105-5115. PubMed ID: 34193942
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the cyld/RIPK1/FADD/caspase-8-dependent apoptosis.
    Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
    Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Utilization and treatment Patterns of Cytoreduction Surgery and Intraperitoneal Chemotherapy in the United States.
    Ellis RJ; Schlick CJR; Yang AD; Barber EL; Bilimoria KY; Merkow RP
    Ann Surg Oncol; 2020 Jan; 27(1):214-221. PubMed ID: 31187369
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. External auditory canal lesion: colorectal metastatic adenocarcinoma.
    James A; Karandikar S; Baijal S
    BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30249727
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular targeting of breast and colon cancer cells by PAR1 mediated apoptosis through a novel pro-apoptotic peptide.
    Ray T; Kar D; Pal A; Mukherjee S; Das C; Pal A
    Apoptosis; 2018 Dec; 23(11-12):679-694. PubMed ID: 30196356
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Poorly Differentiated Clusters Predict a Poor Prognosis for External Auditory Canal Carcinoma.
    Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Kiyomi F; Sakata T; Nakagawa T; Nabeshima K
    Head Neck Pathol; 2019 Jun; 13(2):198-207. PubMed ID: 29846906
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Phase II Study of Irinotecan Plus Panitumumab as Second-Line Therapy for Patients with Advanced Esophageal Adenocarcinoma.
    Yoon H; Karapetyan L; Choudhary A; Kosozi R; Bali GS; Zaidi AH; Atasoy A; Forastiere AA; Gibson MK
    Oncologist; 2018 Sep; 23(9):1004-e102. PubMed ID: 29769385
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.
    Van Der Kraak L; Goel G; Ramanan K; Kaltenmeier C; Zhang L; Normolle DP; Freeman GJ; Tang D; Nason KS; Davison JM; Luketich JD; Dhupar R; Lotze MT
    J Immunother Cancer; 2016; 4():65. PubMed ID: 27777774
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Aspirin in primary and secondary prevention of colorectal carcinomas].
    Schrör K; Rauch B
    Med Monatsschr Pharm; 2013 Nov; 36(11):411-21. PubMed ID: 24640118
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The LEF1/cyld axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells.
    Wu P; Shi KJ; An JJ; Ci YL; Li F; Hui KY; Yang Y; Xu CM
    Cell Death Dis; 2014 Feb; 5(2):e1085. PubMed ID: 24577083
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Rectal carcinoma under 40 years of age: seven-year post-treatment follow-up at a tertiary care hospital in Pakistan.
    Haroon N; Khan S; Alvi R
    J Pak Med Assoc; 2013 Dec; 63(12):1460-3. PubMed ID: 24397084
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study.
    Hompes D; D'Hoore A; Wolthuis A; Fieuws S; Mirck B; Bruin S; Verwaal V
    J Surg Oncol; 2014 May; 109(6):527-32. PubMed ID: 24375059
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mechanisms of obesity-induced gastrointestinal neoplasia.
    Alemán JO; Eusebi LH; Ricciardiello L; Patidar K; Sanyal AJ; Holt PR
    Gastroenterology; 2014 Feb; 146(2):357-373. PubMed ID: 24315827
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Impact of Schwartz enhanced visualization solution on staging colorectal cancer and clinicopathological features associated with lymph node count.
    Chapman B; Paquette C; Tooke C; Schwartz M; Osler T; Weaver D; Wilcox R; Hyman N
    Dis Colon Rectum; 2013 Sep; 56(9):1028-35. PubMed ID: 23929011
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Epidermal growth factor receptor, phosphatidylinositol-3-kinase catalytic subunit/PTEN, and KRAS/NRAS/BRAF in primary resected esophageal adenocarcinomas: loss of PTEN is associated with worse clinical outcome.
    Bettstetter M; Berezowska S; Keller G; Walch A; Feuchtinger A; Slotta-Huspenina J; Feith M; Drecoll E; Höfler H; Langer R
    Hum Pathol; 2013 May; 44(5):829-36. PubMed ID: 23158210
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.